Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC for Bacterial Vaginosis
NCT01841411Phase 4Unknown
- Sponsor
- Minia University
- Start
- Mar 2013
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of acetylcysteine in bacterial vaginosis (BV) (3 arms), sponsored by Minia University. Primary endpoint: Recovery of Bacterial Vaginosis at 1 week. Status: unknown.
02
Drugs
acetylcysteine
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on NCT01841411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01841411.